Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: epinephrine attending: chief complaint: myasthenia major surgical or invasive procedure: thymectomy with medial sternotomy history of present illness: the patient is a 32 y/o female with a h/o myasthenia diagnosed in who presents for a thymectomy. the patient was initially diagnosed during her second trimester of pregnancy. since that time, she has been on a variety of treatments including ivig, plasmapheresis, high-dose steroids, cellcept and rituximab () with mild responses. steroids causes a worsening of her myasthenic symptoms. since that time, she has had persistent symptoms of generalized weakness, difficulty swallowing, and fatigue. she is undergoing thymectomy in an attempt to control her disease. past medical history: seropositive myasthenia since hypercarbic respiratory failure from myasthenic crisis migraine headaches irritable bowel syndrome depression c-section svt following intubation social history: -lives with husband -no tobacco or alcohol use -worked as a social worker family history: -mother with auto-immune hepatitis -cousin with spinal muscular atrophy physical exam: t 98.3 p 83 bp 122/74 r 16 sao2 100% gen - no acute distress, alert and oriented heent - no scleral icterus, no cervical lymphadenopathy, neck supple heart - rrr, nl s1 and s2, no murmurs/gallops/rubs lungs - clear abd - soft, nontender, nondistended, bowel sounds audible ext - no cyanosis/edema neuro - cn ii-xii intact pertinent results: 02:06pm blood wbc-13.3*# rbc-3.44* hgb-9.3* hct-27.5*# mcv-80* mch-27.1 mchc-33.9 rdw-18.5* plt ct-166 02:06pm blood glucose-143* urean-14 creat-0.6 na-138 k-3.6 cl-109* hco3-24 angap-9 brief hospital course: the patient was admitted for a thymectomy with a medial sternotomy which she tolerated well and was transferred to the icu in stable condition. the patient had one chest tube placed in the right pleural space and one chest tube placed in the left pleural space. the patient also had drain placed in each pleural space. neurology was consulted to provide recommendations regarding post-op care. serial abg's, negative inspiratory forces, and vital capacities were obtained to monitor the patient for hypercarbia. as her pain became better controlled, her abg's also improved. this was likely a product of an improvement in her ability to take deeper breaths with better pain control. cellcept and cyclosporine were continued for immunosuppression. serial chest x-rays were obtained to monitor for hemothorax. the patient was transferred to the floor on the post-op day 3. the following day, she was transfused one unit of packed red blood cells for a hct of 22.6. both chest tubes were able to be pulled. the patient was started on po keflex as empiric antibiotic therapy to prevent empyema while she had her drains in. she was discharged in stable condition with her drains. at discharge, her pain was well controlled, she was tolerating a regular diet, and she was able to ambulate without assistance. her negative inspiratory forces and vital capacities were in the normal range throughout her admission and she did not display any symptoms of myasthenia . medications on admission: cyclosporin 150 mg po bid (manufactured by pliva) cellcept mg po bid lexapro 20 mg po qd dapsone 25 mg po qod alternating with 50 mg po qod procrit 40,000 units for hb < 12 ocp - tri-sprintic 28 day cycle fluticasone 50 mcg nasal qd loratidine 10 mg po qd fioricet prn migraines oxycodone prn sinus pain clonazepam 1 mg po prn anxiety b12 shot monthly ivig 20 gm over 4 days every 3 weeks discharge medications: 1. cyclosporine modified 50 mg capsule sig: three (3) capsule po q12h (every 12 hours). 2. mycophenolate mofetil 500 mg tablet sig: two (2) tablet po bid (2 times a day). 3. cephalexin 250 mg capsule sig: one (1) capsule po q6h (every 6 hours). disp:*120 capsule(s)* refills:*0* 4. dapsone 25 mg tablet sig: one (1) tablet po every other day: alternate days with 50mg dose. 5. dapsone 25 mg tablet sig: two (2) tablet po every other day: alternate days with 25mg dose. 6. epoetin alfa 10,000 unit/ml solution sig: () units injection once a month as needed for anemia. 7. vitamin b-12 1,000 mcg/ml solution sig: one (1) injection injection once a month. 8. fluticasone 50 mcg/actuation aerosol, spray sig: one (1) spray nasal once a day. 9. loratadine 10 mg tablet sig: one (1) tablet po once a day. 10. tri-sprintec (28) .18/.215/.25-35 mg-mcg (28) tablet sig: one (1) tablet po once a day. 11. escitalopram 10 mg tablet sig: two (2) tablet po daily (daily). 12. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4-6h (every 4 to 6 hours) as needed. disp:*60 tablet(s)* refills:*0* 13. colace 100 mg capsule sig: one (1) capsule po twice a day as needed for constipation. disp:*40 capsule(s)* refills:*0* discharge disposition: home with service facility: vna of greater / discharge diagnosis: myasthenia discharge condition: stable discharge instructions: call your doctor or seek immediate medical attention if you notice your eyelid drooping, jaw weakness, if you get tired from chewing food, if you have slurred speech, or weakness in your arms or legs. also call your doctor if you experience any fevers, chills, lightheadedness, dizziness, chest pain, shortness of breath, palpitations, sever abdominal pain, nausea/vomiting, or increased redness, bleeding, or drainage from wound. no driving while taking pain medications. no tub baths or swimming. you may use dry dressing to pat your wound dry after a shower. no strenous activity for 1 month. diet as tolerated. followup instructions: provider: , m.d. phone: date/time: 10:30 provider: , . appointment should be in days procedure: transfusion of packed cells other total excision of thymus diagnoses: acidosis acute posthemorrhagic anemia depressive disorder, not elsewhere classified irritable bowel syndrome myasthenia gravis without (acute) exacerbation 

Answer: The patient is high likely exposed to